(NYSE:AOMR)
Recap: EyePoint Pharmaceuticals Q4 Earnings
EyePoint Pharmaceuticals (NASDAQ:EYPT) reported its Q4 earnings results on Thursday, March 3, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Related Posts
Alpine 4’s Subsidiary Vayu Aerospace Inks Drone Sales Agreement With ENSCO
Alpine 4 Holdings Inc (NASDAQ ALPP) subsidiary, Vayu Aerospace Corporation, and ENSCO have entered into a procurement agreement to acquire…
Endo International Q2 EPS $0.03 Down From $0.62 YoY, Sales $569.11M Beat $529.94M Estimate
Endo International (NASDAQ:ENDP) reported quarterly earnings of $0.03 per share. This is a 95.16 percent decrease over earnings of $0.62 per share from the same period last year. The company reported quarterly sales of
RBC Capital Maintains Outperform on Reynolds Consumer, Lowers Price Target to $31
RBC Capital analyst Nik Modi maintains Reynolds Consumer (NASDAQ:REYN) with a Outperform and lowers the price target from $33 to $31.